Showing results (1-10 of 1,021) with videos related to
Sort By:
Pageof 103
Der Urologe. Ausg. A|February 8, 2003
[Gemcitabine in advanced bladder cancer]J Lehmann, M Retz, C Lippert, et al.World Journal of Urology|May 26, 2001
The role of adjuvant chemotherapy for locally advanced bladder cancerJ Lehmann, M Retz, M StöckleDer Urologe. Ausg. A|January 5, 2002
[After-care of bladder carcinoma]M Retz, J Lehmann, B Wullich, et al.Onkologie|November 8, 2003
[Systemic chemotherapy for transitional cell carcinoma of the urothelium]J Lehmann, M Retz, M Hack, et al.The Journal of Urology|December 13, 2002
Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumorM Retz, J Lehmann, E Amann, et al.Der Urologe. Ausg. A|March 9, 2005
[Therapy for systemic urothelial cancer recurrence]J Lehmann, M StöckleCancer Research|December 29, 1998
Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinomaM Retz, J Lehmann, C Röder, et al.Der Urologe. Ausg. A|September 7, 2007
[Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer?]H Suttmann, M Retz, J E Gschwend, et al.European Urology|July 21, 2001
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patientsM Retz, J Lehmann, C Röder, et al.Der Urologe. Ausg. A|June 27, 2009
[Systemic chemotherapy for bladder cancer: news in 2009]M Retz, J E Gschwend, J LehmannPageof 103